Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupport
Contact Us
Search
Close

Crypto Unlocked: New Patent Eligibility Guidance on Blockchain Technology  

By Baldassare Vinti & Alan S. Teran, Ph.D. on September 3, 2025
Email this postTweet this postLike this postShare this post on LinkedIn
blockchain concept illustration in 3d, connected blocks in blockchain.
「 LOGO / BRAND / 3D design 」 
WhatsApp: +917559305753
 Email: shubhamdhage000@gmail.com
Shubham Dhage, Unsplash

The U.S. gave crypto one of its biggest regulatory jolts in years.  With the signing of the Guiding and Establishing National Innovation for U.S. Stablecoins (“GENIUS”) Act stablecoins now have a legal framework. The GENIUS Act is part of a broader push to accelerate the development of emerging technologies in the U.S., from artificial intelligence to quantum computing. That same push is showing up in the patent world, where the U.S. Patent and Trademark Office (“USPTO”) and Patent Trial and Appeal Board (“PTAB”) are beginning to clarify how blockchain-related inventions can clear long-standing Section 101 hurdles.

Just as the GENIUS Act provides clarity for stablecoins, a recent PTAB decision is beginning to provide clarity for blockchain patents. In Ex Parte David L. Newman, the PTAB reversed the Examiner’s rejection of the claims under 35 U.S.C. § 101 and provided some useful discussion of how the USPTO (and patent applicants) should approach blockchain-related patents. The claims at issue relate to “securely storing data across a network in a multi-dimensional distributed database” in order to “process[] license contracts, including computing proportional payments related thereto, using blockchains comprising supplemental fork blocks that comprise custodian addresses.”

The Examiner had rejected the claims as directed to the abstract idea of “payment, distribution, and pricing for two users bound by a contractual relationship,” concluding that the additional elements in the claims do not integrate the abstract idea into a practical application. In the Examiner’s view, the invention simply used “a computer as a tool to perform an abstract idea.” The PTAB agreed in part – acknowledging that the claims involved an abstract idea because “[i]t is well settled that commercial interactions involving payment transactions or contractual agreements, are the type of judicially excepted abstract ideas categorized as methods of organizing human activity.”

However, the Board drew the line at step 2 of the Alice analysis. Unlike the Examiner, the Board determined that the claims integrate the abstract idea into a practical application “by improving the technical functioning of the recited blockchain by transforming it into a multi-dimensional database slidechain that allows for the execution and simultaneous processing of supplemental fork blocks along the slidechain.” In other words, the invention did more than implement a business method on a generic computer—it changed how the blockchain itself operates.  As the Board explained, the claims “recite[] steps that transform the blockchain itself so as to allow for improved processing, i.e., simultaneous processing of supplemental fork blocks along the slidechain… [and] uses the recited abstract idea in a meaningful way beyond generally linking its use to a particular technological environment.”

Section 101 of the Patent Act has historically been a major hurdle for patent applicants attempting to claim improvements in blockchain technology.  But as we discussed in relation to a recent PTAB decision related to quantum computing, patent applicants in blockchain-related industries can now find guidance in decisions like Ex Parte David L. Newman to overcome rejections based on 35 U.S.C. § 101. Specifically, applicants should use their specification to clearly articulate how their invention improves “the performance of a computer” and/or “the functionality of the blockchain and the processing thereof.”

The Proskauer Intellectual Property Team is continuing to monitor the evolving guidance on patent eligibility of emerging technologies. With Congress providing a regulatory framework for stablecoins and the PTAB recognizing technical improvements in blockchain, these parallel developments signal a more supportive environment for innovators. We welcome questions about how these shifts may affect your patent strategy in the crypto and broader emerging technology space.

Photo of Baldassare Vinti Baldassare Vinti

Baldassare (“Baldo”) Vinti heads Proskauer’s Intellectual Property Litigation Group.

Baldo’s practice focuses on litigating patent, false advertising, trade secret, life sciences, trademark and contractual matters in federal and state courts and before the International Trade Commission. He is a seasoned trial attorney responsible…

Baldassare (“Baldo”) Vinti heads Proskauer’s Intellectual Property Litigation Group.

Baldo’s practice focuses on litigating patent, false advertising, trade secret, life sciences, trademark and contractual matters in federal and state courts and before the International Trade Commission. He is a seasoned trial attorney responsible for all aspects of litigation, including Markman hearings, appeals before the Federal Circuit, case preparation and strategy, depositions, motion practice, and settlement negotiations. He has represented clients in high-stakes matters involving a broad range of technologies, including medical devices, diagnostics, immunoassays, prosthetics, pharmaceuticals, dental implants, electronic medical records systems, encryption technology, wound dressings, digital video compression, electronic book delivery and security systems, mobile media technologies, navigation and location-based services, bandwidth management, bar code scanning, lasers , and other technologies. Baldo has represented numerous major corporations, including Arkema S.A., British Telecommunications PLC, Church & Dwight Co., Inc., Henry Schein, Inc., Maidenform Brands Inc., Mitsubishi Electric Corp., Ossur North America Inc., Panasonic Corp., Sony Corp., Welch Foods, Inc., and Zenith Electronics LLC.

In addition, Baldo regularly handles transactional work, including intellectual property due diligence, licensing, intellectual property structural transactions, patentability studies, infringement/non-infringement opinions, and client counseling in intellectual property matters.

Baldo is an author and frequent commentator on patent issues pertaining to medical devices and a host of other intellectual property topics, and has been quoted in the National Law Journal, Bloomberg BNA, Law360, Westlaw Journal and Inside Counsel magazine. He is also a regular contributor of articles published in Medical Product Outsourcing magazine that deal with the medical device industry.

Baldo served as a judicial intern for Hon. John E. Sprizzo of the United States District Court for the Southern District of New York and for Hon. Charles A. LaTorella of the New York Supreme Court.

Read more about Baldassare VintiEmail
Show more Show less
Photo of Alan S. Teran, Ph.D. Alan S. Teran, Ph.D.

Alan S. Teran, Ph.D., is an associate in the Litigation Department and Intellectual Property Group.

His practice focuses on a variety of intellectual property issues, including worldwide patent portfolio development and litigation. Alan also has experience with in-house legal and compliance matters, including…

Alan S. Teran, Ph.D., is an associate in the Litigation Department and Intellectual Property Group.

His practice focuses on a variety of intellectual property issues, including worldwide patent portfolio development and litigation. Alan also has experience with in-house legal and compliance matters, including product counseling, commercial contracts, and privacy.

Alan has expertise in semiconductor devices and fabrication as well as experience with a wide range of technologies, including augmented/virtual reality-based software solutions; material processing operations; control systems; integrated circuits; machine learning-based financial services software; media and mobile technology; medical devices; and secondary batteries.

Alan is a registered patent attorney before the U.S. Patent & Trademark Office; and a Certified Information Privacy Professional in the United States (CIPP/US) with the International Association of Privacy Professionals (IAPP).

Alan received his Ph.D. in Electrical Engineering at the University of Michigan, where his research focused on energy harvesting technologies and semiconductor physics for Internet-of-Things and medical applications.

Read more about Alan S. Teran, Ph.D.Email
Show more Show less
  • Posted in:
    Intellectual Property, Technology and AI
  • Blog:
    The Patent Playbook
  • Organization:
    Proskauer Rose LLP
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
  • About LexBlog
  • The Field We Built
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo